Skip to main content
. 2015 Nov 17;11(1):21–29. doi: 10.2215/CJN.04240415

Figure 2.

Figure 2.

Novel urinary biomarkers are elevated in previously AKI-positive patients at long-term follow-up. Median biomarker concentrations at the time of longitudinal follow-up are displayed for AKI-positive (n=30 except for liver fatty acid–binding protein [L-FABP], for which n=29) compared with AKI-negative (n=18) patients. Error bars represent 25th and 75th percentiles. Cr, creatinine; KIM-1, kidney injury molecule-1; NGAL, neutrophil gelatinase-associated lipocalin.